Hepatocellular carcinoma (HCC)
Conditions
Interventions
Sponsors
Shanghai General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) Participated in the study voluntarily and signed the written informed consent; 2) patients aged 18 to 75 years old; 3) The diagnosis of hepatocellular carcinoma conforms to CSCO guidelines; 4) Antivascular drug therapy; 5) Measurable lesions were confirmed by at least two imaging examination methods (including ultrasound, CT, MRI) and digital subtraction angiography (DSA); there was at least one measurable lesion meeting the RECIST 1.1 standard; 6) Child-pugh grade A or B for liver function; 7) The functions of the heart, kidney, bone marrow and other important organs are basically normal; 8) The patient's physical status is according to the Eastern Cooperative Oncology Group, ECOG) score 0-2; 9) The patient's expected survival time is more than 2 months.
Exclusion criteria
Exclusion criteria: 1) Active brain metastasis, cancerous meningitis, spinal cord compression; 2) Obvious cavitation or necrosis within the tumor; 3) Uncontrolled infection; 4) Poor control of serous cavity effusion; 5) A clear neurological or psychiatric history, including epilepsy or dementia; 6) Patients with iodine allergy; 7) Other exclusion criteria Refer to standard clinical study requirements.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CTP parameters; | — |
Countries
China
Contacts
Public ContactFan Wang
Shanghai General Hospital
Outcome results
None listed